Targovax ASA: First Quarter 2019 Results

May 09, 2019   |   May 2019 Bond Updates
OSLO, Norway, May 9, 2019 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its first quarter 2019 results. A meeting for investors, analysts and press will take place in Oslo ...

View more at: https://www.prnewswire.com:443/news-releases/targovax-asa-first-quarter-2019-results-300846984.html
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/